Breast Cancer Clinical Trials in Los Angeles

Showing 361-380 of 492 trials

MRI to Detect Breast Tumors in Women

NCT00003302

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Breast Cancer

Abramson Cancer Center at Penn Medicine1,500 participantsStarted May 1998

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDNA< 1 mile

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

NCT02946619

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Breast CancerBreast Neoplasms

University of Houston136 participantsStarted Jun 2012

Los Angeles, California, United States • Houston, Texas, United States

MRI to Detect Breast Tumors in Women

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Breast Cancer Trials in Other Cities

Health Benefits of Expressive Writing: Study One

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

STOP Heart Disease in Breast Cancer Survivors Trial

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Other Conditions in Los Angeles